The EuBioX bio-automation system, known as the EuBioX system, play a vital role in advancing the EuLV™ stable lentiviral vector system, especially during the phase of high-throughput monoclonal screening in the development of EuLV™ stable producer cell lines.
The utilization of the EuBioX system allows for high-throughput monoclonal cell screening, resulting in a substantial increase in transduction titer for the ultimately chosen producer cell line. The stable producer cell line system significantly increases lentiviral production yield while concurrently reducing production costs.
More than 10,000 cell clones can be screened and identified in a single round of screening. Incorporating the Cell Picker cell selection instrument in the EuBioX system not only conserves substantial time and minimizes the potential for errors but also introduces traceability, elevating the overall efficiency and manageability of the screening process.
The specialized software integrated into the EuBioX system simplifies the procedure of selecting and confirming monoclonal cells, enabling precise validation of the desired single clones. This software effectively reduces the workload associated with monoclonal screening while elevating the precision of the screening process.
The EuBioX system can automatically record, track, analyze, and select the best-performing monoclonal cell lines. The EuBioX system boosts the throughput and experimental stability of cell line screening, addressing various challenges associated with manual operations. Additionally, it empowers data-guided cell line screening, resulting in a notable enhancement of production efficiency.
.jpg)
